- Home
- BLRX vs WVVI Comparison
BLRX vs WVVI Comparison
Compare BLRX & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- WVVI
- Stock Information
- Founded
- BLRX 2003
- WVVI 1983
- Country
- BLRX Israel
- WVVI United States
- Employees
- BLRX N/A
- WVVI N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- BLRX Health Care
- WVVI Consumer Staples
- Exchange
- BLRX Nasdaq
- WVVI Nasdaq
- Market Cap
- BLRX 17.2M
- WVVI 20.4M
- IPO Year
- BLRX 2011
- WVVI N/A
- Fundamental
- Price
- BLRX $3.81
- WVVI $4.15
- Analyst Decision
- BLRX Strong Buy
- WVVI
- Analyst Count
- BLRX 2
- WVVI 0
- Target Price
- BLRX $19.00
- WVVI N/A
- AVG Volume (30 Days)
- BLRX 32.7K
- WVVI 5.5K
- Earning Date
- BLRX 08-14-2025
- WVVI 11-11-2025
- Dividend Yield
- BLRX N/A
- WVVI N/A
- EPS Growth
- BLRX N/A
- WVVI N/A
- EPS
- BLRX N/A
- WVVI N/A
- Revenue
- BLRX $17,251,000.00
- WVVI $38,384,350.00
- Revenue This Year
- BLRX N/A
- WVVI N/A
- Revenue Next Year
- BLRX N/A
- WVVI N/A
- P/E Ratio
- BLRX N/A
- WVVI N/A
- Revenue Growth
- BLRX 1.19
- WVVI N/A
- 52 Week Low
- BLRX $2.30
- WVVI $3.17
- 52 Week High
- BLRX $26.80
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- BLRX 49.18
- WVVI 38.18
- Support Level
- BLRX $3.68
- WVVI $4.80
- Resistance Level
- BLRX $4.11
- WVVI $5.10
- Average True Range (ATR)
- BLRX 0.24
- WVVI 0.23
- MACD
- BLRX 0.02
- WVVI -0.04
- Stochastic Oscillator
- BLRX 41.50
- WVVI 0.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.